Author

Byong Duk Ye 1

1 University of Ulsan College of Medicine,Seoul,Korea (Republic of)

CAP-ASSISTED ENDOSCOPIC MUCOSAL RESECTION FOR RECTAL NEUROENDOCRINE TUMORS: COMPARISONS WITH CONVENTIONAL ENDOSCOPIC MUCOSAL RESECTION AND ENDOSCOPIC SUBMUCOSAL DISSECTION

Jeong-Mi Lee, Dong-Hoon Yang, Yangsoon Park, Min Seob Kwak, Wan Soo Kim, Sung Wook Hwang, Sang Hyoung Park, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Suk-Kyun Yang

CLINICAL OUTCOME AFTER COLONOSCOPIC POLYPECTOMY OF PATIENTS TAKING DIRECT ORAL ANTICOAGULANTS: COMPARISON WITH CLOPIDOGREL

Gwang-un Kim, Dong-Hoon Yang, Jeongseok Kim, Eun Hye Oh, Namseok Ham, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Jaewon Choe

REAL LIFE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AS INDUCTION THERAPY FOR KOREAN IBD PATIENTS IN WHOM ANTI-TNF TREATMENT FAILED: THE FIRST ASIAN PROSPECTIVE COHORT STUDY

Jeongseok Kim, Nam Seok Ham, Eun Hye Oh, Eun Mi Song, Eun Ja Youn, Eun Ja Kwon, Yun Kyung Cho, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye

SUBCUTANEOUS ADMINISTRATION OF A NOVEL FORMULATION OF CT-P13 (INFLIXIMAB BIOSIMILAR) IS SAFE AND ACHIEVES PROJECTED THERAPEUTIC DRUG LEVELS: A PHASE I STUDY IN HEALTHY SUBJECTS

Rene Westhovens, Dae Hyun Yoo, Stefan Schreiber, Walter Reinish, Shomron Ben-Horin, Byong Duk Ye, Jae Woo Kim, Sang Joon Lee, Yeon Ju Jung, Jee Hye Suh, SunJung Kim, Da Hye Kwak

EARLY INFLIXIMAB TROUGH LEVELS PREDICT LATE EFFICACY OF INFLIXIMAB IN A RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH ACTIVE CROHN'S DISEASE COMPARING CT-P13 AND INNOVATOR INFLIXIMAB

Jae Hee Cheon, Kang-Moon Lee, Young-Ho Kim, Byong Duk Ye, Changsoo Eun, Sung Young Lee, Seul Gi Lee, Joon Ho Lee, Houng Kim, Pamela Selema, Raymond Cheung, Stefan Schreiber

Incidence and indicators of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialized countries: Results from the EXPLORE study

Jesus Kazuo Yamamoto Furusho, Othman Al Harbi, Webber Chan, Enrique Ponce de Leon, Jiaming Qian, Marina V. Shapina, Murat Toruner, Chia-Hung Tu, Byong Duk Ye, Morgane Guennec, Cecilia Sison, Dirk Demuth, Olga Fadeeva, Qasim M Rana-Khan, Alessandro Armuzzi

DEVELOPMENT OF A SUBCUTANEOUS FORMULATION OF CT-P13 (INFLIXIMAB): MAINTENANCE SUBCUTANEOUS ADMINISTRATION MAY ELICIT LOWER IMMUNOGENICITY COMPARED TO INTRAVENOUS TREATMENT

Shomron Ben-Horin, Walter Reinisch, Byong Duk Ye, Rene Westhovens, Dae Hyun Yoo, Sang Joon Lee, Sung Young Lee, Mi Rim Kim, Stefan Schreiber

COMPARISON OF IMMUNOPROFILING BETWEEN COLITIS-ASSOCIATED CANCER AND SPORADIC COLORECTAL CANCER

Jae Seung Soh, Suin Jo, Hyejin Lee, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Suk-Kyun Yang, Ji Hun Kim, Sang-Yeob Kim, Seung-Jae Myung

COMPUTER-AIDED DIAGNOSTIC SYSTEM USING ARTIFICIAL INTELLIGENCE FOR PREDICTING THE NBI INTERNATIONAL COLORECTAL ENDOSCOPIC CLASSIFICATION OF COLORECTAL TUMORS

Jeong-Sik Byeon, Eun Mi Song, Sun Ho Lee, Ki Ju Change, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Beom Hee Park, Nak Kug Kim, Joon Beom Seo

CLINICAL OUTCOMES OF COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSSECTION AND RISK FACTORS ASSOCIATED WITH PIECEMEAL ESD

Myeong-Sook Seo, Dong-Hoon Yang, Min Seob Kwak, Wan Soo Kim, Jeong-Mi Lee, Sung Wook Hwang, Sang Hyoung Park, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang

Item 1 - 10 / 16
1
2